Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lloyd Jones

Showing results (51-60 of 733) with videos related to

Pageof 74
Sort By:
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease PreventionKunal N Karmali, Donald M Lloyd-Jones
Journal of the American College of Cardiology|February 15, 2023
Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, DiseaseDonald M Lloyd-Jones, John T Wilkins
Cardiology Clinics|February 7, 2012
Coronary artery calcium testing: dos and don'tsTamar S Polonsky, Donald M Lloyd-Jones
Journal of the American College of Cardiology|September 26, 2009
The role of biomarkers and genetics in peripheral arterial diseaseMary M McDermott, Donald M Lloyd-Jones
JAMA|July 20, 2021
Novel Lipid-Lowering Therapies to Reduce Cardiovascular RiskJohn T Wilkins, Donald M Lloyd-Jones
Nature Reviews. Cardiology|January 9, 2013
Adding a life-course perspective to cardiovascular-risk communicationKunal N Karmali, Donald M Lloyd-Jones
The New England Journal of Medicine|March 17, 2015
Lowering LDL cholesterol is good, but how and in whom?Neil J Stone, Donald M Lloyd-Jones
Health Technology Assessment (Winchester, England)|February 13, 2009
Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluationH Pilgrim, M Lloyd-Jones, A Rees
Nature Reviews. Cardiology|May 17, 2016
Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patientsJohn T Wilkins, Donald M Lloyd-Jones
Journal of the American Heart Association|April 26, 2017
Implementing Cardiovascular Risk Prediction in Clinical Practice: The Future Is NowKunal N Karmali, Donald M Lloyd-Jones
Pageof 74

Showing results (51-60 of 733) with videos related to

Sort By:
Pageof 74
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease PreventionKunal N Karmali, Donald M Lloyd-Jones
Journal of the American College of Cardiology|February 15, 2023
Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, DiseaseDonald M Lloyd-Jones, John T Wilkins
Cardiology Clinics|February 7, 2012
Coronary artery calcium testing: dos and don'tsTamar S Polonsky, Donald M Lloyd-Jones
Journal of the American College of Cardiology|September 26, 2009
The role of biomarkers and genetics in peripheral arterial diseaseMary M McDermott, Donald M Lloyd-Jones
JAMA|July 20, 2021
Novel Lipid-Lowering Therapies to Reduce Cardiovascular RiskJohn T Wilkins, Donald M Lloyd-Jones
Nature Reviews. Cardiology|January 9, 2013
Adding a life-course perspective to cardiovascular-risk communicationKunal N Karmali, Donald M Lloyd-Jones
The New England Journal of Medicine|March 17, 2015
Lowering LDL cholesterol is good, but how and in whom?Neil J Stone, Donald M Lloyd-Jones
Health Technology Assessment (Winchester, England)|February 13, 2009
Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluationH Pilgrim, M Lloyd-Jones, A Rees
Nature Reviews. Cardiology|May 17, 2016
Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patientsJohn T Wilkins, Donald M Lloyd-Jones
Journal of the American Heart Association|April 26, 2017
Implementing Cardiovascular Risk Prediction in Clinical Practice: The Future Is NowKunal N Karmali, Donald M Lloyd-Jones
Pageof 74